Table 1: Clinicopathological characteristics of patients included in study (N = 41).
N% | ||
Age (years) median 60.0 (range 28-85) | < 50 | 10 (24.4) |
≥ 50 | 31 (75. | |
Tumor size (mm) (range 10-43 mm) | 10 ≤, < 20 | 21 (51.2) |
20 ≤, < 30 | 8 (19.5) | |
30 ≤ | 12 (29.3) | |
HER2 Score | 0 | 4 (9.8) |
1+ | 4 (9.8) | |
2+ (ISH-) | 18 (43.9) | |
2+ (ISH+) | 5 (12.2) | |
3+ | 10 (24.4) | |
Lymph Node metastasis | negative | 25 (61.0) |
positive | 16 (39.0) | |
Stage | 1 | 17 (41.5) |
2A | 14 (34.1) | |
2B | 9 (22.0) | |
3A, B | 0 (0) | |
3C | 1 (2.4) | |
4 | 0 (0) |